rs141946034
Positions:
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_001009944.3(PKD1):c.10531C>G(p.Leu3511Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000941 in 1,606,412 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.00073 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00096 ( 2 hom. )
Consequence
PKD1
NM_001009944.3 missense
NM_001009944.3 missense
Scores
19
Clinical Significance
Conservation
PhyloP100: 0.357
Genes affected
PKD1 (HGNC:9008): (polycystin 1, transient receptor potential channel interacting) This gene encodes a member of the polycystin protein family. The encoded glycoprotein contains a large N-terminal extracellular region, multiple transmembrane domains and a cytoplasmic C-tail. It is an integral membrane protein that functions as a regulator of calcium permeable cation channels and intracellular calcium homoeostasis. It is also involved in cell-cell/matrix interactions and may modulate G-protein-coupled signal-transduction pathways. It plays a role in renal tubular development, and mutations in this gene cause autosomal dominant polycystic kidney disease type 1 (ADPKD1). ADPKD1 is characterized by the growth of fluid-filled cysts that replace normal renal tissue and result in end-stage renal failure. Splice variants encoding different isoforms have been noted for this gene. Also, six pseudogenes, closely linked in a known duplicated region on chromosome 16p, have been described. [provided by RefSeq, Oct 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -8 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.0053860545).
BS2
High AC in GnomAd4 at 111 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PKD1 | NM_001009944.3 | c.10531C>G | p.Leu3511Val | missense_variant | 35/46 | ENST00000262304.9 | NP_001009944.3 | |
PKD1-AS1 | NR_135175.1 | n.304-542G>C | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PKD1 | ENST00000262304.9 | c.10531C>G | p.Leu3511Val | missense_variant | 35/46 | 1 | NM_001009944.3 | ENSP00000262304 | P5 | |
PKD1-AS1 | ENST00000563284.3 | n.195-542G>C | intron_variant, non_coding_transcript_variant | 3 |
Frequencies
GnomAD3 genomes AF: 0.000729 AC: 111AN: 152228Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
111
AN:
152228
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00128 AC: 301AN: 235768Hom.: 1 AF XY: 0.00129 AC XY: 166AN XY: 128520
GnomAD3 exomes
AF:
AC:
301
AN:
235768
Hom.:
AF XY:
AC XY:
166
AN XY:
128520
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000963 AC: 1400AN: 1454184Hom.: 2 Cov.: 30 AF XY: 0.000938 AC XY: 678AN XY: 723104
GnomAD4 exome
AF:
AC:
1400
AN:
1454184
Hom.:
Cov.:
30
AF XY:
AC XY:
678
AN XY:
723104
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000729 AC: 111AN: 152228Hom.: 0 Cov.: 33 AF XY: 0.000766 AC XY: 57AN XY: 74372
GnomAD4 genome
AF:
AC:
111
AN:
152228
Hom.:
Cov.:
33
AF XY:
AC XY:
57
AN XY:
74372
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
1
ALSPAC
AF:
AC:
8
ESP6500AA
AF:
AC:
1
ESP6500EA
AF:
AC:
9
ExAC
AF:
AC:
217
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:2
Benign, criteria provided, single submitter | clinical testing | Athena Diagnostics | Jul 02, 2020 | - - |
Likely benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
Polycystic kidney disease Benign:1
Likely benign, no assertion criteria provided | clinical testing | Department of Pathology and Laboratory Medicine, Sinai Health System | - | The PKD1 p.Leu3511Val variant was identified in 1 of 460 proband chromosomes (frequency: 0.002) from individuals or families with ADPKD in a validation study analyzing PKD1 and PKD2 genes using next-generation sequencing (Rossetti 2012). The variant was also identified in dbSNP (ID: rs141946034) as “NA”, ClinVar (classified as likely benign by Prevention Genetics), the ADPKD Mutation Database (classified likely neutral), and PKD1-LOVD 3.0 (unclassified). This variant was also identified in the NHLBI GO Exome Sequencing Project in 9 of 8588 European American alleles (frequency: 0.001), in 1 of 4386 African American alleles (frequency: 0.0002), and the Exome Aggregation Consortium database (August 8, 2016) in 201 (1 homozygous) of 81294 chromosomes (freq. 0.002) in the following populations: Finnish in 16 of 3556 chromosomes (freq. 0.005), European (Non-Finnish) in 184 of 44310 chromosomes (freq. 0.004), and Latino in 1 of 7714 chromosomes (freq. 0.0001), but was not seen in African, East Asian, Other, and South Asian populations, increasing the likelihood that this may be a low frequency benign variant in certain populations of origin. The variant was also identified in this case with a co-occurring pathogenic PKD1 variant (c.4461delC), increasing the likelihood that the p.Leu3511Val variant does not have clinical significance. The p.Leu3511 residue is conserved in mammals and lower organisms, except the variant amino acid Val is present in chicken, increasing the likelihood that this variant does not have clinical significance. Computational analyses (PolyPhen-2, SIFT, AlignGVGD, BLOSUM, MutationTaster) do not suggest a high likelihood of impact to the protein. The variant occurs outside of the splicing consensus sequence and 2 of 5 in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer, HumanSpliceFinder) predict a greater than 10% difference in splicing. HumanSpliceFinder and MaxEntScan predict an altered 5' splice site in this region and we cannot eliminate the possibility that an exon splice enhancer was modified and may lead to abnormal splicing or creation of a cryptic splice site; this is not very predictive of pathogenicity. In summary, based on the above information, the clinical significance of this variant cannot be determined with certainty at this time although we would lean towards a more benign role for this variant. This variant is classified as likely benign. - |
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Nov 03, 2020 | This variant is associated with the following publications: (PMID: 22383692, 9199561) - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
DEOGEN2
Benign
T;.
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
N
LIST_S2
Benign
T;T
M_CAP
Benign
T
MetaRNN
Benign
T;T
MetaSVM
Benign
T
MutationAssessor
Benign
L;.
MutationTaster
Benign
N;N
PrimateAI
Benign
T
PROVEAN
Benign
N;N
REVEL
Benign
Sift
Benign
T;T
Sift4G
Benign
T;T
Polyphen
B;B
Vest4
MVP
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at